A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19

NCT06147063 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: AZD9838
BIOLOGICAL: Licensed mRNA vaccine
BIOLOGICAL: AZD6563

Sponsor

AstraZeneca